Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of perampanel (E2007) in Japanese patients with refractory partial seizures
jRCT2080220978Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2010
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perampanel in Focal Onset Epilepsy, sponsored by Eisai Co., Ltd. Primary endpoint: Long-term safety of perampanel. Started Jan 2010; status: completed.
02
Drugs
perampanel
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on jRCT2080220978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220978.